Research Article

Dominant-Negative Mutants of a Toxin Subunit: An Approach to Therapy of Anthrax

See allHide authors and affiliations

Science  27 Apr 2001:
Vol. 292, Issue 5517, pp. 695-697
DOI: 10.1126/science.109563

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Abstract

The protective antigen moiety of anthrax toxin translocates the toxin's enzymic moieties to the cytosol of mammalian cells by a mechanism that depends on its ability to heptamerize and insert into membranes. We identified dominant-negative mutants of protective antigen that co-assemble with the wild-type protein and block its ability to translocate the enzymic moieties across membranes. These mutants strongly inhibited toxin action in cell culture and in an animal intoxication model, suggesting that they could be useful in therapy of anthrax.

  • * To whom correspondence should be addressed. E-mail: jcollier{at}hms.harvard.edu

View Full Text